Table 3.
Adjusted Hazard Ratios for Incident ESRD and All-Cause Mortality by Filtration Marker
| Age-sex | 
Multivariablea | 
Multivariablea + eGFRcr | 
Multivariablea + mGFR | 
|||||
|---|---|---|---|---|---|---|---|---|
| HRb (95% CI) | P | HRb (95% CI) | P | HRb (95% CI) | P | HRb (95% CI) | P | |
| ESRD (n=69 events; median follow-up, 13.5 y) | ||||||||
| mGFR | 1.61 (1.07, 2.43) | 0.02 | 2.01 (1.31, 3.11) | 0.002 | 1.55 (0.90, 2.69) | 0.1 | -d | - | 
| eGFRcr | 1.82 (1.33, 2.49) | <0.001 | 1.75 (1.26, 2.45) | 0.001 | -c | - | 1.40 (0.91, 2.17) | 0.1 | 
| eGFRcys | 2.20 (1.55, 3.12) | <0.001 | 2.86 (1.94, 4.22) | <0.001 | 3.37 (1.94, 5.87) | <0.001 | 3.28 (1.90, 5.67) | <0.001 | 
| 1/BTP | 1.68 (1.15, 2.44) | 0.01 | 1.71 (1.14, 2.57) | 0.01 | 1.48 (0.99, 2.23) | 0.06 | 1.53 (1.01, 2.30) | 0.04 | 
| 1/B2M | 1.70 (1.19, 2.44) | 0.004 | 1.87 (1.28, 2.72) | 0.001 | 1.53 (0.95, 2.46) | 0.08 | 1.54 (0.98, 2.42) | 0.06 | 
| All-Cause Mortality (n=95 events; median follow-up, 13.9 y) | ||||||||
| mGFR | 1.16 (0.81, 1.66) | 0.4 | 1.17 (0.80, 1.70) | 0.4 | 1.01 (0.62, 1.65) | 0.9 | -d | - | 
| eGFRcr | 1.28 (0.97, 1.70) | 0.08 | 1.22 (0.89, 1.67) | 0.2 | -c | - | 1.21 (0.80, 1.82) | 0.4 | 
| eGFRcys | 1.44 (1.06, 1.94) | 0.02 | 1.44 (1.04, 1.98) | 0.03 | 1.54 (0.99, 2.41) | 0.06 | 1.68 (1.07, 2.64) | 0.02 | 
| 1/BTP | 1.05 (0.84, 1.32) | 0.6 | 1.02 (0.81, 1.28) | 0.9 | 0.98 (0.79, 1.23) | 0.9 | 1.00 (0.80, 1.26) | 0.9 | 
| 1/B2M | 1.78 (1.28, 2.47) | 0.001 | 1.78 (1.25, 2.53) | 0.001 | 2.02 (1.31, 3.11) | 0.001 | 2.12 (1.38, 3.26) | 0.001 | 
Abbreviations: B2M, β2-microglobulin; BTP, β-trace protein; CI, confidence interval; eGFRcr, creatinine-based estimated glomerular filtration rate; eGFRcys, cystatin C–based estimated glomerular filtration rate; ESRD, end-stage renal disease; HR, hazard ratio; mGFR, measured glomerular filtration rate.
Adjusted for age, sex, duration of diabetes, hemoglobin A1c, hypertension, total cholesterol, and natural logarithm-transformed urinary albumin-creatinine ratio.
Expressed per interquartile decrease in each marker.
No HR reported because eGFRcr already in model for this row.
No HR reported because mGFR already in model for this row.